Wenham, MA, United States of America

James Roger Black


Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:

goldMedal1 out of 832,843 
Other
 patents

Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of James Roger Black

Introduction

James Roger Black is an accomplished inventor based in Wenham, MA (US). He holds a patent that significantly contributes to the field of biochemistry and molecular biology. His work focuses on the FMS-like tyrosine kinase (FLT3) and its binding pockets, which are crucial for understanding various protein interactions.

Latest Patents

James Roger Black's notable patent is centered around the crystal structure of FMS-like tyrosine kinase. This invention relates to the binding pockets of FLT3 and provides a computer-encoded data storage medium with the structure coordinates of these binding pockets. The patent also outlines methods for utilizing these coordinates to solve the structures of homologous proteins or protein complexes. Furthermore, it includes techniques for screening and designing compounds that can bind to the FMS-like tyrosine kinase protein and its homologues. The invention also covers crystallizable compositions and methods for identifying inhibitors of the cytoplasmic domain of the FMS-like tyrosine kinase protein.

Career Highlights

Throughout his career, James Roger Black has made significant strides in the field of protein research. His innovative approaches have led to advancements in understanding the molecular mechanisms of tyrosine kinases, which play a vital role in cell signaling and cancer development.

Collaborations

James has collaborated with notable professionals in his field, including James P Griffith and Carlos H Faerman. These collaborations have further enriched his research and contributed to the success of his inventions.

Conclusion

James Roger Black's contributions to the field of biochemistry through his patent on FMS-like tyrosine kinase highlight the importance of innovation in scientific research. His work not only advances our understanding of protein interactions but also opens new avenues for drug design and therapeutic interventions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…